CD5 negative and CD5 positive splenic marginal B-cell lymphomas have differential cytogenetic patterns

Leukemia Research

Volumn 29, Issue 8, 2005, Pages 981-982

  Gimeno, Eva ^a   Salido, Marta ^a   Solé, Francesc ^a   Florensa, Lourdes ^a   Granada, Isabel ^b   Domingo, Alicia ^c   Woessner, Soledad ^a  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

CD5; Deletion 7q; FISH; P53; Splenic marginal zone B cell lymphomas

Indexed keywords

CD5 ANTIGEN; CYCLIN D1;

ANTIGEN EXPRESSION; B CELL LYMPHOMA; BLOOD; CHROMOSOME 17P; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FISHER EXACT TEST; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; LYMPH NODE; LYMPHOID CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SPLENECTOMY; SPLENIC MARGINAL ZONE B CELL LYMPHOMA; STATISTICAL ANALYSIS;

ANTIGENS, CD5; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, B-CELL; SPLENIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 20544475884     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.02.001     Document Type: Letter

References (10)

1. N. Harris, E.S. Jaffe, J. Diebold, G. Flandrin, H.K. Muller-Hermelink, and J. Vardiman World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia November 1997 J Clin Oncol 17 1999 3835 3849
2. F. Solé, M. Salido, B. Espinet, J.L. Garcia, J.A. Martinez Climent, and I. Granada Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q Haematologica 86 2001 71 77
3. D. Oscier, E. Matutes, A. Gardiner, S. Glyde, S. Mould, and V. Brito-Babapulle Cytogenetic studies in splenic lymphoma with villous lymphocytes Br J Haematol 85 1993 486 491
4. X. Troussard, L. Mauvieux, I. Radford-Weiss, K. Rack, F. Valensi, and R. Garand Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Française d'Hématologie Cellulaire (GFHC) study Br J Haematol 101 1998 712 721
5. J.M. Hernández, J.L. García, N.C. Gutierrez, M. Mollejo, J.A. Martínez-Climent, and T. Flores Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization Am J Pathol 158 2001 843 850
6. R. Boonstra, A. Bosga-Bouwer, G.W. van Imhoff, V. Krause, M. Palmer, and R.W. Coupland Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32 Mod Pathol 16 12 2003 1210 1217
7. S. Giannouli, G. Paterakis, P. Ziakas, D. Anagnostou, and M. Voulgarelis Splenic marginal zone lymphomas with peripheral CD5 expression Haematologica 89 2004 113 114
8. J.A. Ferry, W.I. Yang, L.R. Zukerberg, A.C. Wotherspoon, A. Arnold, and N.L. Harris CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse Am J Clin Pathol 105 1996 31 37
9. A.M. Gruszka-Westwood, R. Hamoudi, E. Matutes, E. Tuset, and D. Catovsky P53 abnormalities in splenic lymphoma with villous lymphocytes Blood 97 2001 3552 3558
10. J.L. Chacon, M. Mollejo, E. Munoz, P. Algara, M. Mateo, and L. Lopez Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients Blood 100 5 2002 1648 1654